reading pharmacy threads from 2024 and half of it aged badly
reading pharmacy threads from 2024 and half of it aged badly. Change my mind, genuinely — I have no stake in being right about this.
A supply notice in one member state made the front page here and had no effect at all where I am.
Read the published reimbursement criteria where I live rather than asking. Took twenty minutes and answered everything.
Assumed a prescription would be honoured across the border. It was not, and the rules are clear once you actually read them.
Sceptical readings welcome. The confident ones are the ones I distrust.
best — the order this archive was captured in
Supply notices are issued nationally. A notice in one member state does not imply availability problems in another, even for the same product.
[deleted]
Yes. Pack sizes differ enough that per-month price comparisons across borders need to be normalised before they mean anything.
Correction: that is the authorisation position, and the question was about reimbursement. Different bodies, different answers.
Yes — keep both the prescription and the receipt. Claims processes ask for both and never at a convenient moment.
The variation between pharmacies inside my own country was larger than the variation I had been chasing across the border.
Left up. It names the member state and the pack size, which is all we ask of a pricing post.
Careful, that guidance is from a different country and this thread is asking about somewhere else entirely.
Correcting myself upthread: the criterion I quoted was updated for this year.
Correcting myself upthread: the criterion I quoted was updated for this year.
Agreed — and normalising pack size before comparing prices is the fix for half these threads.
Small fix — those two prices are for different pack sizes, which accounts for most of the gap.
reimbursement is national, not European, and that is the whole board
Cosigning on cross-border prescriptions. The rules exist and they are narrower than the summaries suggest.
the EMA authorises, member states decide who pays
Disagree. That is one member state’s reimbursement rule and it does not generalise across the union.
Pharmacy margins and dispensing fees are regulated nationally, which explains price differences that otherwise look arbitrary.
Compared prices across two neighbouring countries and found the difference was mostly pack size once I normalised it.
Push back: comparing headline prices across countries without normalising pack size is comparing two different quantities.
private pricing varies enormously between neighbouring countries
Not convinced — cross-border prescription recognition is narrower than you are describing and the exceptions matter.
This. The published reimbursement criteria are the document to read, and most member states do publish them.
The translation cost of dealing with a foreign pharmacy was the thing I had not budgeted for.
That shortage notice was national and does not apply where the question is coming from.
Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.
Asked in my own language at a local pharmacy and got a clearer answer in five minutes than a fortnight of forum reading.
say which country or the thread is useless
Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.
This is the split the whole board depends on. Authorisation is European; payment is national.
Kept the prescription and the receipt for a claim, purely because a thread here told me to. Both were requested.
pharmacy margins are regulated differently in each country
- 1Supply notices are issued nationally. A notice in one member state does not…12 comments in this branch · started by u/arne_ndiaye
- 2This. The published reimbursement criteria are the document to read, and…10 comments in this branch · started by u/fabio_nkemelu